The optimal management of patients with diabetes is a multifaceted issue that requires the concomitant control of blood pressure, glycemic, HbA1c, and lipid levels. While accomplishing those goals may further reduce mortality by an additional 40-60%, less than 10% of the population is able to achieve those modest profiles. Populations that tend to struggle with achieving optimal outcomes are those who are “non-engaged”, perhaps due to personal limitations and/or the lack of resources. The latter is especially notable because, unfortunately, access to care, necessary medications, and beneficial lifestyle modifications are all expensive as well. Furthermore, T2DM rarely travels alone, and the pill burden that is associated with concurrent management of multiple comorbid conditions is frequently taxing to patients.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
From Red Tape to Relief: Rewriting the Rules of Prior Authorization
June 23rd 2025Up to 257 million Americans could benefit from these prior authorization reforms that could have cross-market implications on health care plans administered through commercial insurers, Medicare Advantage, and Medicaid.
Read More
Moving Evidence From Research to Practice: Q&A With Ken Cohen, MD
June 23rd 2025In 2025, each issue of Population Health, Equity & Outcomes will feature a profile of a health system leader transforming care in their area of expertise. This issue spotlights a conversation with Ken Cohen, MD, executive director of translational research at Optum Health.
Read More